Privacy Policy

24/05/2018 21:39

Privacy Policy

Please read our privacy policy carefully to get a clear understanding of how we collect, use, protect or otherwise handle your Personally Identifiable Information in accordance with our website.
This privacy policy has been compiled to better serve those who are concerned with how their ‘Personally Identifiable Information’ (PII) is being used online. PII, is described as a privacy law and information security, is information that can be used on its own or with other information to identify, contact, or locate a single person, or to identify an individual in context.
What personal information do we collect from the people that visit our blog, website or app?

When ordering or registering on our site, as appropriate, you may be asked to enter your name, email address, mailing address or other details to help you with your experience.

When do we collect information?

We collect information from you when you or enter information on our site. Provide us with feedback on our products or services.

How do we use your information?

We may use the information we collect from you when you register, make a purchase, sign up for our newsletter, respond to a survey or marketing communication, surf the website, or use certain other site features in the following ways:
  • To personalize your experience and to allow us to deliver the type of content and product offerings in which you are most interested.
  • Improve our website in order to better serve you.
  • To allow us to better service you in responding to your customer service requests.

How do we protect your information?

  • We do not use vulnerability scanning and/or scanning to PCI standards.
  • We only provide articles and information and never ask for credit card numbers.
  • use regular Malware Scanning.
  • We do not use an SSL certificate

Do we use ‘cookies’?

We do not use cookies for tracking purposes
You can choose to have your computer warn you each time a cookie is being sent, or you can choose to turn off all cookies. You do this through your browser settings. Since browser is a little different, look at your browser’s Help Menu to learn the correct way to modify your cookies.
If you turn cookies off, some features will be disabled. that make your site experience more efficient and may not function properly.
However, you will still be able to place orders .

Third-party disclosure

We do not sell, trade, or otherwise transfer to outside parties your Personally Identifiable Information.

Third-party links

Occasionally, at our discretion, we may include or offer third-party products or services on our website. These third-party sites have separate and independent privacy policies. We therefore have no responsibility or liability for the content and activities of these linked sites. Nonetheless, we seek to protect the integrity of our site and welcome any feedback about these sites.

Users can visit our site anonymously.

Once this privacy policy is created, we will add a link to it on our home page or as a minimum, on the first significant page after entering our website.
Our Privacy Policy link includes the word ‘Privacy’ and can easily be found on the page specified above.
You will be notified of any Privacy Policy changes:
  • On our Privacy Policy Page
Can change your personal information:
  • By emailing us

How does our site handle Do Not Track signals?

We honor Do Not Track signals and Do Not Track, plant cookies, or use advertising when a Do Not Track (DNT) browser mechanism is in place.
Does our site allow third-party behavioral tracking?
It’s also important to note that we do not allow third-party behavioral tracking

COPPA (Children Online Privacy Protection Act)

When it comes to the collection of personal information from children under the age of 13 years old, the Children’s Online Privacy Protection Act (COPPA) puts parents in control. The Federal Trade Commission, United States’ consumer protection agency, enforces the COPPA Rule, which spells out what operators of websites and online services must do to protect children’s privacy and safety online.

We do not specifically market to children under the age of 13 years old.
If at any time you would like to unsubscribe from receiving future emails, you can email us at

and we will promptly remove you from ALL correspondence.

Contacting Us

If there are any questions regarding this privacy policy, you may contact us using the information below




White paper on "Raising Quality Results on Supplier Audits Using EQMS for Pharmaceutical Companies"

09/02/2014 18:48


Supply chain integrity is necessary to a pharmaceutical company’s success. Formal contracts, quality agreements, and product and chemical purchase specifications alone never guarantee supply chain integrity. Astute pharmaceutical companies implement audit processes as an integral component of supply chain management. Audits foster a culture of agreement adherence among partner suppliers. The benefits to both the pharmaceutical company and partner suppliers are mutual and strengthen the professional relationship.


Read further in:



Article: Are Funny People More Successful in Business? - Forbes article

17/10/2013 04:29

Are Funny People More Successful in Business? - Forbes article which can be applied to your career and to adding humor to your training sessions

GMP and Quality, Responsibility, Integrity, and Accountability - Article

15/08/2013 03:07

GMP and Quality, Responsibility, Integrity, and Accountability This article describes how to instill these important character traits into your people to assure commitment to GMP

Wooden's Pyramid of Success - John Wooden's Pyramid of Success

15/08/2013 02:52

Wooden's Pyramid of Success - John Wooden's Pyramid of Success


A good article which is useful for personal growth....

Roche to invest $105M into training center

15/08/2013 02:44

While many companies are scaling back production operations around the world, Roche has seen its logistics and packaging operations in Switzerland grow by about 500 employees in recent years. To keep up with the need for trained employees for the operation, Roche says it will invest $105 million to build a new training center there.


The plant in Kaiseraugst in northern Switzerland handles quality control and drug packaging, and it currently has about 1,600 workers, according to Reuters. It has grown by 30% in the last 5 years. An article from Bilanz says Roche has already invested about SFr400 million ($423 million) in the Swiss plant and that the facility is currently training about 300 people in 14 "careers" to keep up with demand.


The piece says the SFr100 million training center will be a 12,000-square-meter, 5-story facility including lab and classrooms. The company will start work on the new facility in September and expects to have it complete in October 2014, Reuters reported. "The need for education and training opportunities for our employees is increasing," Matthias Baltisberger, head of Roche Basel-Kaiseraugst said in a statement.

Source: FiercePharma Manufacturing

A Major Mistake That Managers Make

22/05/2013 22:14

A Major Mistake That Managers Make - Article by Russ Ackoff, Ph.D.

FDA addresses retention of Internal Audit Reports

22/05/2013 22:11

Do the CGMP regulations permit the destruction of an internal quality assurance

audit report once the corrective action has been completed?

The CGMP regulations (21 CFR 210 and 211) for finished pharmaceutical manufacturing

do not specifically address the requirement to conduct, or to keep records of, internal

quality assurance audits. If the report in question were from a routine audit to verify that

the firm's quality system is operating as intended, then it would be acceptable if the firm

elected to discard the report once all corrections have been verified.

However, any documentation of corrective action as a result of such an audit would have

to be retained (see 211.180 and 211.188). For example, if a routine internal audit finds a

problem with a mixing step and the outcome is a change in mixing time, all affected

procedures, including the master production record, are to reflect the necessary changes,

and such records are subject to FDA inspection as usual. Any investigation into the

impact this problem had on related batches is to be retained and also made available for

inspection by FDA (see 211.192).

In addition, any reports of investigations or evaluations prepared in response to, for

example, a product complaint (211.198), vendor qualification (211.84), periodic review

of records and data (211.180(e)), and a failure investigation (211.192) are not internal

audits as discussed above. Such records are subject to FDA inspection and must be

retained for at least the time specified in the CGMP regulations (see 211.180).


 Preamble to the Current Good Manufacturing Practice in Manufacturing,

Processing, Packing, or Holding regulations; Federal Register, September 29,

1978 (vol. 43, no. 190), page 45015, paragraph 4

 21 CFR 211.84: Testing and approval/rejection of components, drug product

containers, and closures

 21 CFR 211.180: General requirements

 21 CFR 211.192: Production record review

 21 CFR 211.198: Complaint files

 Compliance Policy Guide Sec. 130-300, (7151.02)

Contact for further information:

Rosa Motta, CDER


FDA addresses retention of Internal Audit Reports - Read FDA's response to a question regarding retention of Internal Audit Reports




16/03/2013 22:50


A good presentation on




Its very useful to understand the effectiveness of meeting and conducting meeting effectively....





Why is GMP so important - Answers from the FDA **NEW**

16/03/2013 20:59


Why is GMP so important - Answers from the FDA

Why is GMP so important? This question is answered by the FDA in an article on facts about cGMPs. The FDA gives the answers in a compact form in 6 paragraphs on two pages. Read more.





Items: 1 - 10 of 10